Displaying 551 - 560 of 631
NASHVILLE, TN - Two dedicated endocrinologists, experts in the care of patients with diabetes, have used their songwriting talents to co-write, produce, and record with a former American Idol performer and other recording artists, “Needle-Free”, an anthem of hope for patients with type1 diabetes and a message of awareness of the obstacles those patients face daily.
The promise of a “needle free” life is music to the ears of people who suffer from type1 diabetes – an autoimmune disease wherein the pancreas does not produce the critical hormone insulin. Since the discovery of…
more
JACKSONVILLE, Fla. – (September 22, 2015) – Citing the lack of compelling evidence connecting testosterone replacement therapy (TRT) with cardiovascular events such as heart attack and stroke, physicians representing the
American Association of Clinical Endocrinologists (AACE) today issued a position statement questioning claims that testosterone replacement therapy (TRT) increases the risk of cardiovascular disease among users.
While several recently published studies support the association of low testosterone concentrations with cardiovascular…
more
JACKSONVILLE, Fla. – (February 10, 2016) – Citing glycemic measurement as an essential component of care for all patients with diabetes, the American Association of Clinical Endocrinologists (AACE) today announced the publication of its outpatient glucose monitoring consensus statement.
The statement provides detailed analyses to support precise recommendations for the type of system and frequency of use for either self-monitoring blood glucose (SMBG) therapy or continuous glucose monitoring (CGM) to reduce short- and long-term complications of diabetes.
While acknowledging challenges…
more
JACKSONVILLE, Fla. – (December 21, 2016) – Aiming to revolutionize the diagnosis, treatment and management of obesity, one of the world’s most insidious chronic diseases, the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) today released a bold position statement that redefines the medical diagnostic term for obesity as a far-reaching, complications-centric chronic disease state whose measurement goes beyond the traditional singular focus on Body Mass Index, or BMI.
Labelled by statement authors as…
more
WASHINGTON, D.C. – (February 23, 2016) – A consensus conference convened by the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) this past weekend advocated for expanded use of continuous glucose monitoring (CGM) in the management of diabetes.
The diverse cross-section of diabetes care thought leaders included scientific and medical societies, patient advocacy groups, government, insurance, and pharmaceutical and medical device manufacturers.
The key conclusions concerning CGM use in diabetes include the following…
more
WASHINGTON, D.C. – (September 21, 2016) – A pivotal piece of legislation intended to benefit patients with diabetes and other metabolic, autoimmune and insulin-resistant diseases is headed to the floor of the House of Representatives for a vote after its passage today by the House Energy and Commerce Committee.
The National Clinical Care Commission Act, the top legislative priority of the American Association of Clinical Endocrinologists (AACE), calls for the creation of a public/private sector commission that will draw on the expertise of the country’s foremost…
more
JACKSONVILLE, Fla. – (January 5, 2016) – The American Association of Clinical Endocrinologists (AACE), in conjunction with the American College of Endocrinology (ACE), today announced the publication of its 2016 update of the AACE/ACE Comprehensive Diabetes Management Algorithm and Executive Summary as a clinical guide for physicians managing the care of patients with type 2 diabetes (T2D).
The 2016 algorithm considers new therapies, disease management approaches and key clinical data, resulting in a new section on…
more
JACKSONVILLE, Fla. – (September 20, 2016) – The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) today announced the publication of new clinical practice guidelines and an accompanying algorithm to assist physicians and other medical professionals with the diagnosis, fracture risk assessment and treatment of postmenopausal osteoporosis patients.
The two documents are published in Volume 22, Issue 9 of the association’s peer-reviewed scientific journal
Endocrine… more
As a means to revolutionize the diagnosis, treatment and management of one of the world’s most menacing chronic diseases – obesity, the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) released a bold statement that redefines the medical diagnostic term of obesity – a disease with which more than one-third (36.5 percent) of U.S. adults have been diagnosed, according to the Centers for Disease Control and Prevention (CDC).
The new term developed and introduced by AACE and ACE - Adiposity-Based Chronic Disease or ABCD - focuses on the…
more
JACKSONVILLE, Fla. – (May 15, 2017) – The American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2016 Update and Algorithm were published in September 2016 (
https://www.aace.com/files/postmenopausal-guidelines.pdf).
Most recently, the American College of Physicians (ACP) published new osteoporosis guidelines (…
more